Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Zydus Cadila gets USFDA nod for skin ointment, stomach ailment drug

      Zydus Cadila gets USFDA nod for skin ointment, stomach ailment drug

      Ruby Khatun Khatun28 May 2018 10:30 AM IST
      New Delhi: Zydus Cadila has received final approval from the US health regulator to market Nystatin ointment and Omeprazole and Sodium Bicarbonate...
      Sun Pharma warns US pricing pressure to hit 2019 profit

      Sun Pharma warns US pricing pressure to hit 2019 profit

      Ruby Khatun Khatun28 May 2018 10:15 AM IST
      India’s largest drugmaker Sun Pharmaceutical Industries said it expects it's 2019 revenue to come in short of analysts’ expectations due to pricing...
      Divis Labs Q4 profit rises 0.89 percent at Rs 261 crore

      Divis Labs Q4 profit rises 0.89 percent at Rs 261 crore

      Ruby Khatun Khatun28 May 2018 10:00 AM IST
      New Delhi: Drug firm Divis Laboratories reported a 0.89% rise in its standalone net profit to Rs261.60 crore for the fourth quarter ended 31 March.The...
      FDA permits marketing of artificial intelligence algorithm for aiding providers in detecting wrist fractures

      FDA permits marketing of artificial intelligence algorithm for aiding providers in detecting wrist fractures

      Ruby Khatun Khatun28 May 2018 9:45 AM IST
      The U.S. Food and Drug Administration (FDA) permitted marketing of Imagen OsteoDetect, a type of computer-aided detection and diagnosis software...
      US jury fails to reach verdict in latest Johnson and Johnson talc trial

      US jury fails to reach verdict in latest Johnson and Johnson talc trial

      Ruby Khatun Khatun28 May 2018 9:30 AM IST
      NEW YORK: A South Carolina jury could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson and Johnson’s Baby...
      Pacemaker, X-rays, MRI machines soon under Drugs and Cosmetics Act

      Pacemaker, X-rays, MRI machines soon under Drugs and Cosmetics Act

      Ruby Khatun Khatun27 May 2018 3:03 PM IST
      New Delhi: The government will soon regulate the manufacture, import, sale and price of the all implantable medical devices and other high end...
      Cadila Healthcare Q4 profit rises 53 percent at Rs 590.8 crore

      Cadila Healthcare Q4 profit rises 53 percent at Rs 590.8 crore

      Ruby Khatun Khatun27 May 2018 10:30 AM IST
      New Delhi: Cadila Healthcare on Friday reported 53.26% jump in consolidated net profit at Rs 590.8 crore for the fourth quarter ended 31 March...
      Lupin submits marketing authorization application for Etanercept biosimilar in Europe

      Lupin submits marketing authorization application for Etanercept biosimilar in Europe

      Ruby Khatun Khatun27 May 2018 10:15 AM IST
      Mumbai: Pharma major Lupin announced that its Marketing Authorization Application (MAA) for a biosimilar of Etanercept has been accepted for review by...
      Johnson and Johnson jury asks judge to slap cancer warning on baby powder: Report

      Johnson and Johnson jury asks judge to slap cancer warning on baby powder: Report

      Ruby Khatun Khatun27 May 2018 10:00 AM IST
      If Johnson and Johnson (J&J) won’t put a warning on its baby powder that it may be tainted with asbestos, some jurors were ready to do it for...
      Zydus Wellness Q4 net rises 22 percent to Rs 36 crore

      Zydus Wellness Q4 net rises 22 percent to Rs 36 crore

      Ruby Khatun Khatun27 May 2018 9:45 AM IST
      New Delhi: Zydus Wellness reported a 21.93 percent increase in consolidated net profit at Rs 36.25 crore for the quarter ended March 2018.The company...
      AstraZeneca cancer drug hits second goal by extending survival

      AstraZeneca cancer drug hits second goal by extending survival

      Ruby Khatun Khatun27 May 2018 9:30 AM IST
      LONDON: AstraZeneca’s immunotherapy drug Imfinzi has hit a second important goal by improving overall survival in lung cancer patients, boosting...
      Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales

      Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales

      Ruby Khatun Khatun27 May 2018 9:15 AM IST
      MELBOURNE: An Australian court dismissed an appeal by the nation’s anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok